CRYODERM
CRYODERM, licence 80022198: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- AHC Ventures Inc.
- NPN or DIN-HM
- 80022198
- Status
- Active licence
- Licence date
- 8 November 2010
- Revision date
- 14 March 2012
- Form
- Gel
- Route of administration
- Topique
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
propylèneglycol, Arnica, acrylates/C-10-30 Alkyl Acrylate Crosspolymer, Huile de menthe poivrée, Essence d'Eucalyptus, triéthanolamine, Acide citrique anhydre, Eau purifiée, alcool dénaturé, extrait de feuilles de Ilex paraguayensis ( extrait de feuilles d'herbe du Paraguay), Boswellia, Diméthyl sulfone
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2.0 Année(s) | Not specified | maximum: 4.0 Tous les jours |
| Adultes | Not specified | Not specified | maximum: 4.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporary Pain Reliever. For the temporary relief of aches and pains. Temporarily relieves minor pain associated with arthritis, simple backaches, joint pain, tendonitis, muscle strains, muscle sprains and bruises.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80022198
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2012. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.